Show Summary Details
Page of

(p. 173) Medications 

(p. 173) Medications
Chapter:
(p. 173) Medications
Author(s):

Jan Willer

DOI:
10.1093/med:psych/9780190256319.003.0013
Page of

PRINTED FROM OXFORD CLINICAL PSYCHOLOGY ONLINE (www.oxfordclinicalpsych.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Clinical Psychology Online for personal use (for details see Privacy Policy and Legal Notice).

date: 29 September 2020

An understanding of medication treatment for ADHD is helpful to educate clients about the benefits and to facilitate collaboration with psychiatrists and other prescribers. Psychotherapy is helpful for organizational skills but leaves the client with continued cognitive difficulties. Stimulant medications effectively address these cognitive problems and are currently considered the most scientifically validated treatment of ADHD. Stimulant medications are well tolerated by clients and have been prescribed safely for decades. Only one nonstimulant medication, atomoxetine (brand name Strattera), has been approved by the FDA for adults with ADHD. Individuals with ADHD may be reluctant to take medication. In these cases, psychotherapists are directed to inquire about the client’s concerns about medication. Some people with ADHD function well without medication. This is an understudied area of research, so little is known.

Access to the complete content on Oxford Clinical Psychology requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.